Passa al contenuto
Merck
  • Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test.

Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test.

Addiction biology (2013-05-03)
Zu-In Su, Jennifer Wenzel, Aaron Ettenberg, Osnat Ben-Shahar
ABSTRACT

We have previously shown that extended-access subjects exhibit heightened motivation for cocaine in the runway model, as reflected by reduced number of retreats. This heightened motivation could reflect either an increase in cocaine-induced reward or a decrease in cocaine-induced aversion. The current experiment was therefore devised to assess the cocaine-induced reward and aversion in extended-access rats using a place conditioning test. Rats trained to lever press for intravenous (IV) cocaine (0.25 mg/infusion) were provided 6-hour daily access to the drug over 10 days. Lever pressing in control subjects produced IV infusions of saline. Following drug self-administration, subjects underwent place conditioning for the immediate or delayed effects of cocaine (1.0 or 2.5 mg/kg, IV). In control subjects, the immediate effects of the low dose of cocaine produced conditioned places preferences (CPPs), while the delayed effects produced conditioned place aversions (CPAs). In contrast, the animals receiving low cocaine dose for 6 hours, exhibited place aversions but not preferences; an effect that was reversed when the dose of cocaine was increased. Additionally, in the 6-hour group, delayed conditioning was associated with a reduction in zif268 immunoreactivity in the medial prefrontal cortex and nucleus accumbens shell while immediate conditioning was associated with an increase in zif268-positive cells in the central nucleus of the amygdala. Collectively, these data suggest that extended daily access to cocaine produces a shift in the subject's perceived reward threshold that is paralleled by alterations in the activity of both the reward and stress pathways.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Dimetil solfossido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetil solfossido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetil solfossido, Molecular Biology
Sigma-Aldrich
Dimetil solfossido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetil solfossido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Dimetil solfossido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Perossido di idrogeno, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Dimetil solfossido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Perossido di idrogeno, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Dimetil solfossido, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
3,3′-Diaminobenzidine tetrahydrochloride hydrate, ≥96%
Millipore
Perossido di idrogeno, 3%, suitable for microbiology
Supelco
Perossido di idrogeno, ≥30%, for trace analysis
Sigma-Aldrich
Dimetil solfossido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Goat Serum Donor Herd, USA origin, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Dimetil solfossido, PCR Reagent
Sigma-Aldrich
Perossido di idrogeno, 34.5-36.5%
Supelco
Perossido di idrogeno, 30 % (w/w), for ultratrace analysis
Supelco
Dimetil solfossido, analytical standard
Supelco
Dimetil solfossido, for inorganic trace analysis, ≥99.99995% (metals basis)
USP
Dimetil solfossido, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Perossido di idrogeno, tested according to Ph. Eur.
Dimetil solfossido, European Pharmacopoeia (EP) Reference Standard